BC
BLUE

Birchview Capital’s bluebird bio BLUE Stock Holding History

Birchview Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,560
Closed -$110K – 69
2024
Q3 		$110K Sell
10,560
-5,000
-32% -$83.1K 0.1% 51
2024
Q2 		$306K Sell
15,560
-500
-3% -$10K 0.28% 44
2024
Q1 		$411K Hold
16,060
– – 0.34% 39
2023
Q4 		$443K Sell
16,060
-6,700
-29% -$408K 0.35% 36
2023
Q3 		$1.38M Buy
22,760
+10,300
+83% +$723K 1.18% 14
2023
Q2 		$820K Buy
12,460
+2,500
+25% +$183K 0.61% 28
2023
Q1 		$633K Buy
9,960
+5,060
+103% +$578K 0.5% 28
2022
Q4 		$678K Hold
4,900
– – 0.48% 28
2022
Q3 		$620K Hold
4,900
– – 0.44% 35
2022
Q2 		$406K Buy
4,900
+700
+17% +$54.3K 0.3% 41
2022
Q1 		$407K Hold
4,200
– – 0.29% 44
2021
Q4 		$839K Sell
4,200
-2,285
-35% -$539K 0.54% 32
2021
Q3 		$1.6M Buy
6,485
+772
+14% +$221K 1.09% 16
2021
Q2 		$2.37M Sell
5,713
-116
-2% -$46K 1.42% 12
2021
Q1 		$2.28M Buy
5,829
+1,043
+22% +$514K 1.35% 14
2020
Q4 		$2.68M Buy
4,786
+154
+3% +$97.6K 1.55% 14
2020
Q3 		$3.24M Hold
4,632
– – 2.16% 7
2020
Q2 		$3.66M Buy
+4,632
New +$3.49M 2.21% 7

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Birchview Capital's BLUE Position: Q4 2024 in Review

Birchview Capital sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 10,560 shares — an estimated $110K sold.

Birchview Capital first reported a position in BLUE in Q2 2020 and held it in 18 quarters. The position peaked at $3.66M in Q2 2020. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Birchview Capital reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Birchview Capital sold 10,560 bluebird bio shares in Q4 2024, an estimated $110K.
  • Birchview Capital first reported a position in bluebird bio in Q2 2020 and held it in 18 quarters.
  • Birchview Capital's bluebird bio position peaked at $3.66M in Q2 2020.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Birchview Capital's 13F filing for Q4 2024, filed 14 Feb 2025.